Renal tubular and adrenal medullary tumors in the 2-year rat study with canagliflozin confirmed to be secondary to carbohydrate (glucose) malabsorption in the 15-month mechanistic rat study
Chemico-Biological Interactions(2017)
Abstract
During preclinical development of canagliflozin, an SGLT2 inhibitor, treatment-related pheochromocytomas, renal tubular tumors (RTT), and testicular Leydig cell tumors were reported in the 2-year rat toxicology study.
MoreTranslated text
Key words
Canagliflozin,SGLT2 inhibitor,SGLT1 inhibitor,Kidney tumors,Pheochromocytomas,Adrenal medullary hyperplasia,Carbohydrate malabsorption
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined